Literature DB >> 9373107

Efficacy of proton therapy in circumscribed choroidal hemangiomas associated with serious retinal detachment.

D Hannouche1, E Frau, L Desjardins, N Cassoux, J L Habrand, H Offret.   

Abstract

OBJECTIVE: The purpose of the study is to evaluate the efficacy and safety of proton therapy in complicated circumscribed choroidal hemangiomas.
DESIGN: The study design was a retrospective review. PARTICIPANTS: Studied were 13 patients (13 eyes) who had circumscribed choroidal hemangioma associated with serous retinal detachment. Of these, four eyes previously underwent laser unsuccessfully. INTERVENTION: Proton therapy including a total dose of 30 Cobalt-Gray-Equivalent was administered to each eye. MAIN OUTCOME MEASURES: Patients were controlled for initial and final best-corrected visual acuity, slit-lamp examination, intraocular pressure, fundus examination, fluorescein angiography, and tumor thickness on B-scan ultrasonography.
RESULTS: The mean follow-up period was 26 months (range, 9-48 months). Retinal reattachment was obtained in all cases after a mean period of 52 days. The tumor height decreased in all cases. Visual acuity improved to two lines or more in eight eyes (62%) and reached 20/200 or more in nine eyes (69%). No radiation complication was detected during follow-up.
CONCLUSIONS: Proton radiation seems to be effective and safe in the management of choroidal hemangioma associated with serous retinal detachment. It may be useful when photocoagulation can not be performed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373107     DOI: 10.1016/s0161-6420(97)30026-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Transpupillary thermotherapy in the treatment of circumscribed choroidal hemangiomas.

Authors:  Raul N G Vianna; Luiza Fernandes; Acácio Muralha; Aderbal Alves Júnior; Lilia Muralha; Eduardo Muranaka
Journal:  Int Ophthalmol       Date:  2004-03       Impact factor: 2.031

2.  Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma.

Authors:  B Jurklies; G Anastassiou; S Ortmans; A Schüler; H Schilling; U Schmidt-Erfurth; N Bornfeld
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

3.  Treatment review of sight threatening circumscribed choroidal haemangioma.

Authors:  James Ft Li Yim; Teresa Sandinha; Jan M Kerr; Diana Ritchie; Ewan G Kemp
Journal:  Int J Ophthalmol       Date:  2010-06-18       Impact factor: 1.779

4.  Long-term (4 years) results of choroidal hemangioma treated with proton beam irradiation.

Authors:  A Zeisberg; I Seibel; D Cordini; N Lakotka; G Willerding; L Moser; J Heufelder; A M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-29       Impact factor: 3.117

Review 5.  Photodynamic therapy of circumscribed choroidal haemangioma.

Authors:  A D Singh; P K Kaiser; J E Sears; M Gupta; P A Rundle; I G Rennie
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

6.  Vascular tumors of the retina and choroid: diagnosis and treatment.

Authors:  Mary E Turell; Arun D Singh
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

7.  Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy.

Authors:  F D Verbraak; R O Schlingemann; J E E Keunen; M D de Smet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-18       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.